SCHEMBL29298629

SCHEMBL29298629

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccccc4)nc(-c4cc(-c5ccccc5)c5oc6cc7ccccc7cc6c5c4)n3)c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.35
MAPT P10636 8/20 0.34
KDM4E B2RXH2 6/20 0.34
ALDH1A1 P00352 6/20 0.34
POLB P06746 2/20 0.34
KMT2A Q03164 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
RAB9A P51151 3/20 0.33
MEN1 O00255 3/20 0.33
HTT P42858 2/20 0.33
NPC1 O15118 2/20 0.33
MAOB P27338 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TSHR P16473 4/20 0.33
LMNA P02545 2/20 0.33
GPR35 Q9HC97 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HSD17B10 Q99714 3/20 0.32
TP53 P04637 2/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24586567 0.96 MAPT (0.36) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL24585647 0.96 MAPT (0.36) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL25708412 0.96 MAPT (0.36) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL24066103 0.96 MAPT (0.36) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL25666490 0.96 MAPT (0.36) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL29298626 0.96 NUDT1 (0.37) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL29298627 0.95 MAPT (0.33) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL24548800 0.94 PIM1 (0.34) NUDT1MAPTKDM4EALDH1A1POLB
SCHEMBL29298623 0.93 ALDH1A1 (0.37) NUDT1MAPTKDM4EALDH1A1KMT2A
SCHEMBL24586564 0.91 KDM4E (0.41) NUDT1MAPTKDM4EALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER CYP1A1, CYP1B1, CYP2E1 NUDT1 313/4885MAPT 1117/4885KDM4E 3419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.